An OX40/OX40L interaction directs successful immunity to hepatitis B virus

MLA

Amanda Goodsell, et al. “An OX40/OX40L Interaction Directs Successful Immunity to Hepatitis B Virus.” Science Translational Medicine, vol. 10, no. 433, Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d06dd19afebfcd1e9dce2e4b81281f37&authtype=sso&custid=ns315887.

APA

Amanda Goodsell, Ugur Halac, Joyce Judge, Jody L. Baron, Lia Avanesyan, Keith Mansfield, Stewart Cooper, Eric Pai, Michael Croft, Philip J. Rosenthal, Stephen L. Nishimura, Meghan Holdorf, Adil E. Wakil, Arya Koshti, Jillian M. Jespersen, Jean Publicover, Audra J. Johnson, & Anuj Gaggar. (2017). An OX40/OX40L interaction directs successful immunity to hepatitis B virus. Science Translational Medicine, 10(433).

Chicago

Amanda Goodsell, Ugur Halac, Joyce Judge, Jody L. Baron, Lia Avanesyan, Keith Mansfield, Stewart Cooper, et al. 2017. “An OX40/OX40L Interaction Directs Successful Immunity to Hepatitis B Virus.” Science Translational Medicine 10 (433). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d06dd19afebfcd1e9dce2e4b81281f37&authtype=sso&custid=ns315887.